S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 09:42 PM ET

EHAB

Enhabit Inc

Price Chart

No historical data available

Latest Quote

$13.80

+0.01 (+0.07%)
Current Price
Previous Close $13.79
Open $13.79
Day High $13.81
Day Low $13.79
Volume 652,845
Fetched: 2026-06-20T01:42:46
Stock Information
Shares Outstanding 51.23M
Total Debt $480.10M
Cash Equivalents $50.00M
Revenue $1.06B
Net Income $-3.20M
Sector Healthcare
Industry Medical Care Facilities
Market Cap $706.91M
EPS (TTM) $-0.07
Exchange NYQ
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$1.17B
Sales$1.06B
Income$-3.20M
Book/sh$10.53
Cash/sh$0.98
Employees11K
Financial Ratios
Quick Ratio1.46
Current Ratio1.56
Debt/Eq82.22
EPS Growth TTM7.90%
Returns & Margins
ROA3.08%
ROE-0.19%
Gross Margin48.90%
Operating Margin4.38%
Profit Margin-0.30%
Ownership
Insider Ownership3.66%
Institutional Ownership100.64%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E20.87
P/S0.66
P/B1.31
Analyst Data
Recommendationhold
Target Price$13.80
Technical Indicators
SMA20$13.75
SMA50$13.76
SMA200$10.26
RSI75.00
ATR0.0250
Shares Float44.62M
Short Float2.44%
Short Ratio1.18
Volatility0.96
Rel Volume1.32
Performance History
Week+0.22%
Month+0.66%
Quarter+22.99%
6 Months+72.72%
YTD+51.82%
Year+31.81%
3 Years+2.15%
10 Years-44.80%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
No history data available. Data will be fetched automatically.
About Enhabit Inc

Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $540,200,000 $530,800,000 $535,600,000 $525,600,000
Cost Of Revenue $540,200,000 $530,800,000 $535,600,000 $525,600,000
Total Revenue $1,060,000,000 $1,034,800,000 $1,046,300,000 $1,071,100,000
Operating Revenue $1,060,000,000 $1,034,800,000 $1,046,300,000 $1,071,100,000
Expenses
Interest Expense $34,000,000 $42,900,000 $43,000,000 $15,000,000
Total Expenses $996,200,000 $988,200,000 $1,008,100,000 $973,500,000
Other Income Expense $-28,600,000 $-161,700,000 $-85,600,000 $-108,100,000
Other Non Operating Income Expenses $19,100,000 - $200,000 $900,000
Net Non Operating Interest Income Expense $-33,800,000 $-42,900,000 $-43,000,000 $-15,000,000
Interest Expense Non Operating $34,000,000 $42,900,000 $43,000,000 $15,000,000
Operating Expense $456,000,000 $457,400,000 $472,500,000 $447,900,000
General And Administrative Expense $433,500,000 $425,900,000 $441,600,000 $414,900,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-4,600,000 $-156,200,000 $-80,500,000 $-40,400,000
Net Interest Income $-33,800,000 $-42,900,000 $-43,000,000 $-15,000,000
Interest Income $200,000 $0 $0 -
Normalized Income $33,083,000 $1,406,329 $-5,519,912 $45,710,000
Net Income From Continuing And Discontinued Operation $-4,600,000 $-156,200,000 $-80,500,000 $-40,400,000
Total Operating Income As Reported $16,100,000 $-115,100,000 $-47,600,000 $-11,400,000
Net Income Common Stockholders $-4,600,000 $-156,200,000 $-80,500,000 $-40,400,000
Net Income $-4,600,000 $-156,200,000 $-80,500,000 $-40,400,000
Net Income Including Noncontrolling Interests $-2,600,000 $-154,000,000 $-79,000,000 $-38,300,000
Net Income Continuous Operations $-2,600,000 $-154,000,000 $-79,000,000 $-38,300,000
Pretax Income $1,400,000 $-158,000,000 $-90,400,000 $-25,500,000
Special Income Charges $-47,700,000 $-161,700,000 $-85,800,000 $-109,000,000
Interest Income Non Operating $200,000 $0 $0 -
Operating Income $63,800,000 $46,600,000 $38,200,000 $97,600,000
Depreciation Amortization Depletion Income Statement $22,500,000 $31,500,000 $30,900,000 $33,000,000
Depreciation And Amortization In Income Statement $22,500,000 $31,500,000 $30,900,000 $33,000,000
Gross Profit $519,800,000 $504,000,000 $510,700,000 $545,500,000
Earnings From Equity Interest - - $0 $0
Per Share
Diluted EPS - $-3.11 $-1.61 $1.26
Basic EPS - $-3.11 $-1.61 $1.26
Other
Tax Effect Of Unusual Items $-10,017,000 $-4,093,671 $-10,819,912 $-22,890,000
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $105,600,000 $78,100,000 $69,300,000 $131,500,000
Total Unusual Items $-47,700,000 $-161,700,000 $-85,800,000 $-109,000,000
Total Unusual Items Excluding Goodwill $-47,700,000 $-161,700,000 $-85,800,000 $-109,000,000
Reconciled Depreciation $22,500,000 $31,500,000 $30,900,000 $33,000,000
EBITDA (Bullshit earnings) $57,900,000 $-83,600,000 $-16,500,000 $22,500,000
EBIT $35,400,000 $-115,100,000 $-47,400,000 $-10,500,000
Diluted NI Availto Com Stockholders $-4,600,000 $-156,200,000 $-80,500,000 $-40,400,000
Minority Interests $-2,000,000 $-2,200,000 $-1,500,000 $-2,100,000
Tax Provision $4,000,000 $-4,000,000 $-11,400,000 $12,800,000
Impairment Of Capital Assets $47,700,000 $161,700,000 $85,800,000 $109,000,000
Selling General And Administration $433,500,000 $425,900,000 $441,600,000 $414,900,000
Other Gand A $433,500,000 $425,900,000 $441,600,000 $414,900,000
Diluted Average Shares - $50,200,000 $49,900,000 $49,700,000
Basic Average Shares - $50,200,000 $49,900,000 $49,600,000
Fetched: 2026-05-15
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-359,800,000 $-434,600,000 $-472,000,000 $-505,700,000
Total Assets $1,167,100,000 $1,226,000,000 $1,433,600,000 $1,526,800,000
Total Non Current Assets $961,500,000 $1,033,300,000 $1,223,500,000 $1,315,000,000
Other Non Current Assets $2,400,000 $4,700,000 $5,300,000 $5,200,000
Goodwill And Other Intangible Assets $893,800,000 $958,100,000 $1,141,700,000 $1,247,400,000
Other Intangible Assets $38,500,000 $58,100,000 $80,000,000 $102,600,000
Current Assets $205,600,000 $192,700,000 $210,100,000 $211,800,000
Other Current Assets $16,100,000 $13,200,000 $15,600,000 $23,600,000
Restricted Cash $1,900,000 $1,900,000 $2,400,000 $4,300,000
Receivables $144,000,000 $149,200,000 $164,700,000 $161,000,000
Accounts Receivable $144,000,000 $149,200,000 $164,700,000 $149,600,000
Allowance For Doubtful Accounts Receivable $-1,200,000 $-900,000 $-1,100,000 $-1,100,000
Gross Accounts Receivable $145,200,000 $150,100,000 $165,800,000 $150,700,000
Cash Cash Equivalents And Short Term Investments $43,600,000 $28,400,000 $27,400,000 $22,900,000
Cash And Cash Equivalents $43,600,000 $28,400,000 $27,400,000 $22,900,000
Taxes Receivable - - $3,000,000 $11,400,000
Prepaid Assets - - - -
Debt
Net Debt $404,700,000 $487,000,000 $525,200,000 $560,200,000
Total Debt $500,000,000 $569,500,000 $610,100,000 $625,200,000
Long Term Debt And Capital Lease Obligation $465,100,000 $534,400,000 $575,800,000 $588,100,000
Long Term Debt $426,000,000 $492,600,000 $530,100,000 $560,000,000
Current Debt And Capital Lease Obligation $34,900,000 $35,100,000 $34,300,000 $37,100,000
Current Debt $22,300,000 $22,800,000 $22,500,000 $23,100,000
Other Current Borrowings $22,300,000 $22,800,000 $22,500,000 $23,100,000
Liabilities
Total Liabilities Net Minority Interest $603,000,000 $672,100,000 $731,900,000 $751,500,000
Total Non Current Liabilities Net Minority Interest $476,700,000 $545,900,000 $594,200,000 $618,600,000
Other Non Current Liabilities $100,000 - $1,300,000 $1,900,000
Non Current Deferred Liabilities $11,500,000 $11,500,000 $17,100,000 $28,600,000
Non Current Deferred Taxes Liabilities $11,500,000 $11,500,000 $17,100,000 $28,600,000
Current Liabilities $126,300,000 $126,200,000 $137,700,000 $132,900,000
Other Current Liabilities $41,800,000 $47,300,000 $40,700,000 $40,700,000
Payables And Accrued Expenses $49,600,000 $43,800,000 $62,700,000 $55,100,000
Payables $9,200,000 $6,700,000 $15,800,000 $12,100,000
Accounts Payable $9,200,000 $6,700,000 $7,600,000 $3,800,000
Other Payable - $5,400,000 $8,200,000 $8,300,000
Total Tax Payable - - - $0
Income Tax Payable - - - $0
Equity
Common Stock Equity $534,000,000 $523,500,000 $669,700,000 $741,700,000
Total Equity Gross Minority Interest $564,100,000 $553,900,000 $701,700,000 $775,300,000
Stockholders Equity $534,000,000 $523,500,000 $669,700,000 $741,700,000
Gains Losses Not Affecting Retained Earnings $0 $-200,000 $-500,000 $-700,000
Retained Earnings $93,700,000 $98,300,000 $254,500,000 $335,000,000
Other Equity Adjustments - $-200,000 $-500,000 $-700,000
Other
Treasury Shares Number $471,790 $219,851 $114,331 -
Ordinary Shares Number $50,723,245 $50,369,917 $50,053,375 $50,099,716
Share Issued $51,195,035 $50,589,768 $50,167,706 $50,099,716
Tangible Book Value $-359,800,000 $-434,600,000 $-472,000,000 $-505,700,000
Invested Capital $982,300,000 $1,038,900,000 $1,222,300,000 $1,324,800,000
Working Capital $79,300,000 $66,500,000 $72,400,000 $78,900,000
Capital Lease Obligations $51,700,000 $54,100,000 $57,500,000 $42,100,000
Total Capitalization $960,000,000 $1,016,100,000 $1,199,800,000 $1,301,700,000
Minority Interest $30,100,000 $30,400,000 $32,000,000 $33,600,000
Treasury Stock $3,800,000 $1,700,000 $600,000 $0
Additional Paid In Capital $443,600,000 $426,600,000 $415,800,000 $406,900,000
Capital Stock $500,000 $500,000 $500,000 $500,000
Common Stock $500,000 $500,000 $500,000 $500,000
Preferred Stock $0 $0 - -
Long Term Capital Lease Obligation $39,100,000 $41,800,000 $45,700,000 $28,100,000
Current Capital Lease Obligation $12,600,000 $12,300,000 $11,800,000 $14,000,000
Current Accrued Expenses $40,400,000 $37,100,000 $46,900,000 $43,000,000
Goodwill $855,300,000 $900,000,000 $1,061,700,000 $1,144,800,000
Net PPE $65,300,000 $70,500,000 $76,500,000 $62,400,000
Accumulated Depreciation $-65,700,000 $-55,000,000 $-55,400,000 $-52,400,000
Gross PPE $131,000,000 $125,500,000 $131,900,000 $114,800,000
Leases $4,000,000 $3,200,000 $3,100,000 $3,000,000
Other Properties $49,800,000 $52,800,000 $57,500,000 $42,000,000
Machinery Furniture Equipment $77,200,000 $69,500,000 $71,300,000 $69,800,000
Properties $0 $0 $0 $0
Dueto Related Parties Current - - - -
Fetched: 2026-05-15
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $65,800,000 $47,400,000 $44,900,000 $73,000,000
Operating Activities
Operating Cash Flow $70,700,000 $51,200,000 $48,400,000 $80,100,000
Cash Flow From Continuing Operating Activities $70,700,000 $51,200,000 $48,400,000 $80,100,000
Operating Gains Losses $-19,200,000 - - -
Investing Activities
Capital Expenditure $-4,900,000 $-3,800,000 $-3,500,000 $-7,100,000
Investing Cash Flow $16,700,000 $-2,400,000 $-5,300,000 $-42,300,000
Cash Flow From Continuing Investing Activities $16,700,000 $-2,400,000 $-5,300,000 $-42,300,000
Net Other Investing Changes $600,000 $1,400,000 $1,000,000 $1,100,000
Capital Expenditure Reported - - - -
Financing Activities
Financing Cash Flow $-72,200,000 $-48,300,000 $-40,500,000 $-18,600,000
Cash Flow From Continuing Financing Activities $-72,200,000 $-48,300,000 $-40,500,000 $-18,600,000
Net Other Financing Charges $-4,500,000 $-4,700,000 $-7,100,000 $61,300,000
Cash Dividends Paid - $0 $0 $-654,900,000
Common Stock Dividend Paid - $0 $0 $-654,900,000
Dividend Received Cfo - - - -
Other
Repayment Of Debt $-67,700,000 $-43,600,000 $-33,400,000 $-15,000,000
Interest Paid Supplemental Data $32,400,000 $42,700,000 $40,600,000 $13,100,000
Income Tax Paid Supplemental Data $1,400,000 - - $11,900,000
End Cash Position $45,500,000 $30,300,000 $29,800,000 $27,200,000
Beginning Cash Position $30,300,000 $29,800,000 $27,200,000 $8,000,000
Changes In Cash $15,200,000 $500,000 $2,600,000 $19,200,000
Net Issuance Payments Of Debt $-67,700,000 $-43,600,000 $-33,400,000 $575,000,000
Net Long Term Debt Issuance $-67,700,000 $-43,600,000 $-33,400,000 $575,000,000
Long Term Debt Payments $-67,700,000 $-43,600,000 $-33,400,000 $-15,000,000
Net Investment Purchase And Sale $21,000,000 $0 $0 -
Sale Of Investment $21,000,000 $0 $0 -
Net Business Purchase And Sale $0 $0 $-2,800,000 $-36,300,000
Purchase Of Business $0 $0 $-2,800,000 $-36,300,000
Net PPE Purchase And Sale $-4,900,000 $-3,800,000 $-3,500,000 $-7,100,000
Purchase Of PPE $-4,900,000 $-3,800,000 $-3,500,000 $-7,100,000
Change In Working Capital $3,800,000 $5,100,000 $11,700,000 $-29,200,000
Change In Other Current Liabilities $-5,400,000 $-10,200,000 $400,000 $7,500,000
Change In Payables And Accrued Expense $6,300,000 $-3,300,000 $6,800,000 $-30,800,000
Change In Accrued Expense $3,700,000 $-2,300,000 $3,000,000 $-31,000,000
Change In Payable $2,600,000 $-1,000,000 $3,800,000 $200,000
Change In Account Payable $2,600,000 $-1,000,000 $3,800,000 $200,000
Change In Prepaid Assets $-2,300,000 $3,100,000 $19,100,000 $-27,500,000
Change In Receivables $5,200,000 $15,500,000 $-14,600,000 $21,600,000
Changes In Account Receivables $5,200,000 $15,500,000 $-14,600,000 $21,600,000
Other Non Cash Items $1,900,000 $900,000 $1,700,000 $700,000
Stock Based Compensation $16,600,000 $11,700,000 $8,900,000 $9,200,000
Asset Impairment Charge $47,700,000 $161,700,000 $85,800,000 $109,000,000
Deferred Tax $0 $-5,700,000 $-11,600,000 $-4,300,000
Deferred Income Tax $0 $-5,700,000 $-11,600,000 $-4,300,000
Depreciation Amortization Depletion $22,500,000 $31,500,000 $30,900,000 $33,000,000
Depreciation And Amortization $22,500,000 $31,500,000 $30,900,000 $33,000,000
Gain Loss On Investment Securities $-19,200,000 - - -
Net Income From Continuing Operations $-2,600,000 $-154,000,000 $-79,000,000 $-38,300,000
Issuance Of Debt - $0 $0 $590,000,000
Long Term Debt Issuance - $0 $0 $590,000,000
Earnings Losses From Equity Investments - - $0 $0
Net Intangibles Purchase And Sale - - - -
Purchase Of Intangibles - - - -
Fetched: 2026-05-15